Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1992 Nov;85(11):682–685. doi: 10.1177/014107689208501109

Generic prescribing of antidepressants.

P Bruck 1, C A Antao 1, J A Henry 1
PMCID: PMC1293727  PMID: 1474553

Abstract

Analysis of National Health Service prescription data for the antidepressants from 1980 to 1989 shows a consistent secular trend towards the increased use of generic names on prescriptions for this group of drugs. This apparently reflects national trends for all drugs, and was similar for most antidepressants. However, generic prescribing had by 1989 increased significantly more rapidly with fluvoxamine, which was introduced in 1987. The two drugs introduced in 1989, fluoxetine and amoxapine, also had a high generic prescribing rate in their year of introduction. Increased generic prescribing may become a feature with further new drugs. However, the use of the generic name on the prescription has relatively little influence on what is dispensed to the patient. Pharmacists may dispense a brand name when given a generic prescription. Moreover, pressures on doctors to write generic names on prescriptions may have limited relevance for some drugs; generic alternatives were available for only four out of 22 antidepressants.

Full text

PDF
682

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R. J., Reilly P. M. Generic alternatives in general practice. Br Med J (Clin Res Ed) 1984 Apr 14;288(6424):1129–1131. doi: 10.1136/bmj.288.6424.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Archer M. What use is generic prescribing? J R Coll Gen Pract. 1985 Jun;35(275):293–295. [PMC free article] [PubMed] [Google Scholar]
  3. Aronoff G. M. Trazodone associated with priapism. Lancet. 1984 Apr 14;1(8381):856–856. doi: 10.1016/s0140-6736(84)92307-9. [DOI] [PubMed] [Google Scholar]
  4. Bower A. D., Burkett G. L. Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices. J Fam Pract. 1987 Jun;24(6):612–616. [PubMed] [Google Scholar]
  5. Collier J. The cases for and against prescribing generic drugs: generic prescribing benefits patients. BMJ. 1988 Dec 17;297(6663):1596–1598. doi: 10.1136/bmj.297.6663.1596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cruickshank J. M. The cases for and against prescribing generic drugs: don't take innovative research based pharmaceutical companies for granted. BMJ. 1988 Dec 17;297(6663):1597–1598. doi: 10.1136/bmj.297.6663.1597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dubovsky S. L. Severe nortriptyline intoxication due to change from a generic to a trade preparation. J Nerv Ment Dis. 1987 Feb;175(2):115–117. doi: 10.1097/00005053-198702000-00009. [DOI] [PubMed] [Google Scholar]
  8. Hill A. Generic prescribing--a change of habit. J R Coll Gen Pract. 1985 Feb;35(271):89–90. [PMC free article] [PubMed] [Google Scholar]
  9. Huskisson E. C. Trade names or proper names? A problem for the prescriber. Br Med J. 1973 Oct 27;4(5886):225–228. doi: 10.1136/bmj.4.5886.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McAdam N. W. Patients' attitudes to generic prescribing. J R Coll Gen Pract. 1986 Jun;36(287):288–288. [PMC free article] [PubMed] [Google Scholar]
  11. Ostroff R. B., Docherty J. P. Tricyclics, bioequivalence, and clinical response. Am J Psychiatry. 1978 Dec;135(12):1560–1561. doi: 10.1176/ajp.135.12.1560. [DOI] [PubMed] [Google Scholar]
  13. Peabody C. A., Whiteford H. A., Hollister L. E. Antidepressants and the elderly. J Am Geriatr Soc. 1986 Dec;34(12):869–874. doi: 10.1111/j.1532-5415.1986.tb07261.x. [DOI] [PubMed] [Google Scholar]
  14. Rosenbaum J. F., Falk W. E., Gastfriend D. R., Gross C. C., Pollack M. H., Tesar G. E., Weilburg J. B. Acute distress after switch from Norpramin to generic desipramine. Am J Psychiatry. 1989 Jan;146(1):122–122. doi: 10.1176/ajp.146.1.122a. [DOI] [PubMed] [Google Scholar]
  15. Scher M., Krieger J. N., Juergens S. Trazodone and priapism. Am J Psychiatry. 1983 Oct;140(10):1362–1363. doi: 10.1176/ajp.140.10.1362. [DOI] [PubMed] [Google Scholar]
  16. Wade D. N. Drugs, drug products and prescribing habits. Drugs. 1971;2(5):447–453. doi: 10.2165/00003495-197102050-00003. [DOI] [PubMed] [Google Scholar]
  17. van Zwanenberg T. D., Grant G. B., Gregory D. A. Can rational prescribing be assessed? J R Coll Gen Pract. 1987 Jul;37(300):308–310. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES